A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population
Revision as of 23:18, 11 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population; S Livadas, M Dracopoulou, C Lazaropoulouae; 2009; doi_citing_unknown == Retraction == Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11ß-hydroxylase deficiency ; Firdevs Bas Nucin Saka Feyza Darendeliler Siki Tuzlah Ridvan Ilhan Ruveyde Bundak Hulya Gonuz...")
Target ArticleEdit
A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population; S Livadas, M Dracopoulou, C Lazaropoulouae; 2009; doi_citing_unknown
RetractionEdit
Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11ß-hydroxylase deficiency ; Firdevs Bas Nucin Saka Feyza Darendeliler Siki Tuzlah Ridvan Ilhan Ruveyde Bundak Hulya Gonuz; 06/01/2000
Citation pieceEdit
Note: Open to append information.